Ulsanic 1g Tablet / Efferverscent / Supension
PDF Leaflet Revision Date: 26 October 2012
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of gastric and duodenal ulcers, chronic gastritis, and reflux oesophagitis.
Dosage (summary)
1 g three to four times daily between meals; maintenance: 1 g twice daily.
Special Populations
- Renal impairment
- Elderly
Pregnancy & Breastfeeding
Safety not established in pregnancy; unknown if excreted in breast milk.
Key Drug Interactions
- Cimetidine
- Ranitidine
- Digoxin
- Ketoconazole
- Phenytoin
- Fluoroquinolone antibacterials
- Tetracycline
- Levothyroxine
- Quinidine
- Theophylline
- Warfarin
Contraindications
- Hypersensitivity to sucralfate or excipients
Common side effects
- Constipation
- Dizziness
- Drowsiness
- Skin rashes
- Pruritus
Counselling Points
- Take between meals
- Dissolve effervescent tablets in water
- Monitor for dizziness or drowsiness
Serious warnings
- Caution in renal impairment due to aluminium absorption
- Risk of bezoar formation
Important Disclaimer
The Ulsanic 1g Tablet / Efferverscent / Supension professional information leaflet below is the property of Aspen Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
